10 newer rulings cite the same tariff codes.
Classification can shift over time. Review the more recent rulings below before relying on this one.
The tariff classification of Fluticasone Propionate (CAS-80474-14-2), imported in bulk form; and CUTIVATE® Cream, CUTIVATE® Ointment, FLONASE® Nasal Spray, FLOVENT® Inhalation Aerosol, and FLOVENT® ROTADISK®, imported put up in measured doses or in forms or packings for retail sale, from the United Kingdom, France, Italy, Canada, Singapore, etc.
Issued April 18, 2000 by U.S. Customs and Border Protection.
Cite this ruling
Copies to clipboardF8 F85460 (April 18, 2000)
Tariff classification
HTS codes: 2937.22.0000, 3004.39.0050
Product description
The first product, Fluticasone Propionate, is a synthetic fluorinated corticosteroid indicated for use as an anti-inflammatory and antipruritic drug, and also for use in the treatment of asthma and allergic rhinitis. The remaining products, namely: CUTIVATE® Cream, CUTIVATE® Ointment, FLONASE® Nasal Spray, FLOVENT® Inhalation Aerosol, and FLOVENT® ROTADISK® are all medicaments containing Fluticasone Propionate as the active ingredient. CUTIVATE® Cream and CUTIVATE® Ointment are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. FLONASE® Nasal Spray is indicated for the management of the nasal symptoms of seasonal and perennial allergic rhinitis. FLOVENT® Inhalation Aerosol is indicated for the maintenance treatment of asthma as prophylactic therapy, and is also indicated for patients requiring oral corticosteroid therapy for asthma. FLOVENT® ROTADISK® is indicated for the maintenance treatment of asthma as prophylactic therapy, and is also indicated for patients requiring oral corticosteroid therapy for asthma.
CBP rationale
The applicable subheading for Fluticasone Propionate, imported in bulk form, will be 2937.22.0000, Harmonized Tariff Schedule of the United States (HTS), which provides for "[H]alogenated derivatives of adrenal cortical hormones. The applicable subheading for CUTIVATE® Cream, CUTIVATE® Ointment, FLONASE® Nasal Spray, FLOVENT® Inhalation Aerosol, and FLOVENT® ROTADISK® will be 3004.39.0050, HTS, which provides for “[M]edicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale: Containing hormones or other products of heading 2937 but not containing antibiotics: Other: Other.
Full text
NY F85460 April 18, 2000 CLA-2-29:RR:NC:2:238 F85460 CATEGORY: Classification TARIFF NO.: 2937.22.0000; 3004.39.0050 Robert L. Eisen, Esq. Christopher E. Pey, Esq. Coudert Brothers 1114 Avenue of the Americas New York, NY 10036-7703 RE: The tariff classification of Fluticasone Propionate (CAS-80474-14-2), imported in bulk form; and CUTIVATE® Cream, CUTIVATE® Ointment, FLONASE® Nasal Spray, FLOVENT® Inhalation Aerosol, and FLOVENT® ROTADISK®, imported put up in measured doses or in forms or packings for retail sale, from the United Kingdom, France, Italy, Canada, Singapore, etc. Dear Messrs. Eisen and Pey: In your letter dated April 6, 2000, on behalf of your client, Glaxo Wellcome Inc., you requested a tariff classification ruling. The first product, Fluticasone Propionate, is a synthetic fluorinated corticosteroid indicated for use as an anti-inflammatory and antipruritic drug, and also for use in the treatment of asthma and allergic rhinitis. The remaining products, namely: CUTIVATE® Cream, CUTIVATE® Ointment, FLONASE® Nasal Spray, FLOVENT® Inhalation Aerosol, and FLOVENT® ROTADISK® are all medicaments containing Fluticasone Propionate as the active ingredient. CUTIVATE® Cream and CUTIVATE® Ointment are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. FLONASE® Nasal Spray is indicated for the management of the nasal symptoms of seasonal and perennial allergic rhinitis. FLOVENT® Inhalation Aerosol is indicated for the maintenance treatment of asthma as prophylactic therapy, and is also indicated for patients requiring oral corticosteroid therapy for asthma. FLOVENT® ROTADISK® is indicated for the maintenance treatment of asthma as prophylactic therapy, and is also indicated for patients requiring oral corticosteroid therapy for asthma. The applicable subheading for Fluticasone Propionate, imported in bulk form, will be 2937.22.0000, Harmonized Tariff Schedule of the United States (HTS), which provides for "[H]alogenated derivatives of adrenal cortical hormones." The general rate of duty will be free. The applicable subheading for CUTIVATE® Cream, CUTIVATE® Ointment, FLONASE® Nasal Spray, FLOVENT® Inhalation Aerosol, and FLOVENT® ROTADISK® will be 3004.39.0050, HTS, which provides for “[M]edicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale: Containing hormones or other products of heading 2937 but not containing antibiotics: Other: Other.” The general rate of duty will be free. This merchandise may be subject to the requirements of the Federal Food, Drug, and Cosmetic Act, which is administered by the U.S. Food and Drug Administration. You may contact them at 5600 Fishers Lane, Rockville, Maryland 20857, telephone number 301-443-1544. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 212-637-7068. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification and country of origin of Calcitonin Salmon Injection, USP in dosage form
The tariff classification of Leuprolide Acetate Injection in dosage form, from India
The tariff classification of Liraglutide Injection Pen in dosage form, from China
The tariff classification of ORABLOC® (Articaine Hydrochloride 4% and Epinephrine 1100,000 and 1200,000) Injection in dosage form, from Italy
The tariff classification of Estradiol Tablets in dosage form, from India
The tariff classification of Exemestane Tablets in dosage form, from China
The tariff classification of Exemestane Tablets in dosage form, from India
The tariff classification of Levothyroxine Sodium for Injection in dosage form, from India
The tariff classification of Levothyroxine Sodium Tablets in dosage form, from India
The tariff classification of Abiraterone Acetate Tablets in dosage form, from China
Follow F85460
Get an email if this ruling is revoked or modified, or a newer ruling supersedes it.
One email per day at most. Confirm your address once, unsubscribe anytime.
Searching CBP rulings the smart way
Rulings are precedent. See which ones apply to your product: TariffLens semantically searches all 200,000+ CBP rulings and builds defensible classifications backed by ruling citations.